Permutation testing demonstrated borderline significance (pR2Y = 0.246, pQ2 = 0.057).
← all excerpts
Metabolomics Approach Identifies Predictive Serum Markers for Hepatocellular Carcinogenesis Following Hepatitis C Virus Elimination
1
—
—
Permutation testing demonstrated borderline significance (pR2Y = 0.246, pQ2 = 0.057).